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Regulation of the Dynamic Chromatin Architecture of
the Epidermal Differentiation Complex Is Mediated by
a c-Jun/AP-1-Modulated Enhancer
Inez Y. Oh1, Danielle M. Albea1, Zane A. Goodwin1, Ashley M. Quiggle1, Breeana P. Baker1,
Ann M. Guggisberg1, Jessica H. Geahlen1, Grace M. Kroner1 and Cristina de Guzman Strong1
The epidermal differentiation complex (EDC) locus comprises a syntenic and linear cluster of genes whose
concomitant expression is a hallmark feature of differentiation in the developing skin epidermis. Many of the
EDC proteins are cross-linked together to form the cornified envelope, an essential and discrete unit of the
mammalian skin barrier. The mechanism underlying coordinate transcriptional activation of the EDC is unknown.
Within the human EDC, we identified an epidermal-specific regulatory enhancer, 923, which responded to the
developmental and spatiotemporal cues at the onset of epidermal differentiation in the mouse embryo.
Comparative chromosomal conformation capture assays in proliferating and differentiated primary mouse
keratinocytes revealed multiple physiologically sensitive chromatin interactions between the 923 enhancer and
EDC gene promoters, thus depicting the dynamic chromatin topology of the EDC. We elucidate a mechanistic
link between c-Jun/AP-1 and 923, whereby AP-1- and 923-mediated EDC chromatin remodeling are required for
functional EDC gene activation. Thus, we identify a critical enhancer/transcription factor axis governing the
dynamic regulation of the EDC chromatin architecture and gene expression and provide a framework for future
studies toward understanding gene regulation in cutaneous diseases.
Journal of Investigative Dermatology (2014) 134, 2371–2380; doi:10.1038/jid.2014.44; published online 27 February 2014
INTRODUCTION
The epidermis lies at the surface of the skin and provides the
first line of defense against the external environment (Koster
and Roop, 2007; Fuchs, 2009; Kubo et al., 2012). Protecting
against infection and inflammation, the epidermis comprises
stratified layers of epidermal cells or keratinocytes that are
individually surrounded by a cornified envelope and function
as one of the essential core units of the skin barrier. To build
the epidermal barrier akin to a ‘‘bricks-and-mortar’’
architecture, a basal keratinocyte in the innermost layer of
the epidermis receives an inductive cue to differentiate and
orients its mitotic spindle perpendicularly to the basement
membrane (Lechler and Fuchs, 2005). In doing so, an
asymmetric cell division gives rise to a basal cell and a
suprabasal daughter cell that is committed to terminal
differentiation. As the keratinocyte completes the differen-
tiation process, it is pushed upward and sequentially through
the spinous and granular layers, and finally to the outermost
stratum corneum.
A hallmark feature for the execution of the terminal
epidermal differentiation program is the expression of genes
encoded by the epidermal differentiation complex (EDC) locus
(Mischke et al., 1996; Zhao and Elder, 1997; Marshall et al.,
2001; de Guzman Strong et al., 2010). The EDC (located on
human 1q21 and mouse 3q) consists of four gene families that
are associated with skin barrier formation: small proline-rich
region (SPRR), late cornified envelope (LCE), filaggrin (FLG)
and FLG-like (FLG-like), and S100 genes. Genes encoded in
the EDC are coordinately activated during embryonic
epidermal differentiation (de Guzman Strong et al., 2010).
Exciting and recent studies in mice have identified a role for
epigenetics in the regulation of the EDC during skin
development (reviewed in Botchkarev et al., 2012).
Epidermal-specific loss of Ezh2, an essential component of
the polycomb repressor complex for histone modification,
resulted in early epidermal differentiation owing to precocious
recruitment of AP-1 transcription factor to the EDC for
gene expression (Ezhkova et al., 2009). Furthermore, Satb1,
a higher-order genome organizer, was recently identified
as a p63 target and binds to the EDC (Fessing et al., 2011).
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Satb1 / mice exhibited alterations in the chromatin
conformation of the EDC resulting in defects in keratinocyte-
specific and EDC gene expression and hence abnormal
epidermal morphology, and further demonstrated a require-
ment for the proper establishment of higher-order EDC
chromatin structure and coordinated gene expression. This
was further supported by confocal microscopy and comput-
ational modeling, which identified distinct and active
remodeling of the nuclear architecture associated with gene
expression specifically in the terminally differentiated
keratinocyte (Gdula et al., 2013). Comprehensive studies of
the b-globin locus control region and the X-inactivation center
further support evidence for causality of chromatin folding and
three-dimensional genome organization with respect to gene
regulation (Deng et al., 2012; Nora et al., 2012). However,
despite these studies, the molecular mechanism(s) that
underlies activation and coordinates regulation of the EDC
genes at the nucleotide level is unknown. The synteny and
linearity of the EDC across a wide range of mammalian
species suggest a molecular mechanism originating at the
proximal genomic level.
One plausible model is the activation of critical EDC
expression by cis-regulatory elements during skin barrier
formation. Comparative genomics and the Encyclopedia of
DNA Elements (ENCODE) consortium, which has annotated
80% of the genome attributed to function, have greatly
facilitated identification of regulatory elements (Dunham
et al., 2012). We previously identified many conserved
noncoding elements (CNEs) within the human EDC that
could synergistically or independently coordinate EDC gene
expression (de Guzman Strong et al., 2010). Approximately
50% of them exhibit regulatory activity. CNE 923
(approximately 923 kb from the transcriptional start site of
S100A10, the most 50 EDC gene) displayed the strongest
enhancer activity in proliferating and differentiated
keratinocytes in our functional screen. This result corrobor-
ated with transgenic reporter mice that demonstrated
epidermal-specific enhancer activity for CNE 923 in vivo.
This led us to hypothesize a role for 923 in the coordinate
transcriptional activation of the EDC.
Here, we tracked the activity of CNE 923 during develop-
ment in transgenic mice and identified spatiotemporal sensi-
tivity for 923 that coincides with the onset and patterning of
epidermal differentiation. Chromosomal conformation capture
(3C) studies were used to determine the physical interactions
between 923 and EDC gene promoters and revealed multiple
chromatin spatial interactions surrounding 923. Comparative
3C analyses between proliferating and differentiated primary
keratinocytes revealed a dynamic 923-centric EDC chromatin
domain associated with concomitant EDC gene expression.
Comparative genomics and genetic studies identified an AP-1
transcription factor–binding site within 923 that was required
for enhancer activity. We determine that the AP-1-binding site
in 923 is functionally relevant, as pharmacological inhibition
of AP-1 in calcium-induced keratinocytes repressed EDC gene
expression, and was associated with aberrant chromatin
remodeling and loss of c-Jun/AP-1 binding to 923. Thus,
our results provide a framework to examine molecular
mechanisms that link DNA sequence to chromatin architec-
ture and biological functions relevant to development and
disease.
RESULTS
923 Is an epidermal-specific enhancer responsive to the spatial
and temporal cues in the developing mouse epidermis
We previously observed that human CNE 923 exhibited
epidermal-specific enhancer activity, driving lacZ expression
in G0 transgenic mice (923-hsp68-lacZ), which was analyzed
only at mouse embryonic day (E)16.5 (de Guzman Strong
et al., 2010). However, the onset and the spatial and temporal
patterning for 923 during mouse embryonic development
were unclear. To address this, we generated additional
923-hsp68-lacZ transgenic mice. 923 Enhancer activity (as
measured by lacZ transcript levels) was detected as early as
E15.5 in the developing mouse epidermis (Figure 1e), and
coincided with the onset of early epidermal differentiation, as
demonstrated by positive keratin 1 (K1) expression (Figure 1d),
and activation of involucrin (Ivl), Flg, and loricrin (Lor)
(Figure 1e). X-galactose reactivity (blue) was not detectable
at E15.5 in whole mount or cross-sections of the epidermis
(Figure 1a and b) owing to the lack of b-galactosidase protein
expression. At E16.5 and E17.5, we observed expression of
923 enhancer activity correlating with the patterning of barrier
acquisition (dorsal to ventral migration pattern (Hardman
et al., 1998); Figure 1a). 923 Enhancer activity was localized
to the spinous to stratum corneum layers of the dorsal
epidermis at E16.5 and E17.5 (Figure 1b). Failure to detect
b-galactosidase activity on the dorsal epidermis of E17.5
whole-mount embryos is consistent with barrier acquisition
that precludes substrate penetration to detect b-galactosidase
activity. Together, the data support the responsiveness of 923
enhancer activity to the spatiotemporal cues of the developing
mouse epidermis.
The dynamic chromatin architecture of the EDC
We previously identified DNaseI hypersensitivity for 923 (de
Guzman Strong et al., 2010) and note the ENCODE-annotated
H3K4me1 histone modification mark in proliferating primary
human keratinocytes that independently tags functional
enhancers (Ernst et al., 2011; Figure 3a). Enhancers are known
to form long-range physical interactions with target gene
promoters for activation (Tolhuis et al., 2002). Given these
observations and the spatiotemporal sensitivity in the
developing mouse epidermis, we hypothesized a role for
923 in mediating the chromatin conformation of the EDC.
To test this hypothesis, 3C assays coupled with quantitative
PCR (qPCR; Hage`ge et al., 2007) were used in proliferating
and differentiated primary mouse keratinocytes to detect
physical chromatin interactions at the sub-megabase level
between the endogenous mouse 923 ortholog and the EDC
genes. 923 Formed multiple interactions with EDC gene pro-
moters (9 out of 46 tested queries, Sprr2a1, Sprr2d, Sprr2f,
Sprr1b, Sprr3, Ivl, Lce1b, Lce1a2, and Crct1 (cysteine-rich
C-terminal 1)) in proliferating keratinocytes despite the lack of
EDC gene expression relative to the differentiated keratino-
cytes (Figure 2a and b). In differentiated keratinocytes, a
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reconfiguration of the EDC chromatin state was identified and
was associated with 11 923-mediated chromatin spatial
interactions between a HindIII fragment 50 of Lce3b and
S100a6, Sprr2a1, Sprr2b, Sprr3, Sprr4, Ivl, Lce6a, Lce1b,
Lce1e, and Crct1 gene promoters, and was relatively consis-
tent with their expression during terminal differentiation
(Figure 2a and b). In comparison with proliferating cells, the
observed interactions in differentiated keratinocytes that were
lost included Sprr2d, Sprr2f, and Sprr1b, and Lce1a2 (within
250 kb of 923), as well as a gain with 50 of Lce3b, S100a6,
Sprr2b, Sprr4, Lce6a, and Lce1e. Notably, the gain of 923’s
interaction with S100a6 was located 2 Mb away across a gene
desert and observed higher frequencies of interactions with
Sprr2a1 and Sprr2b (both 4250 kb away from 923). All of the
above genes with the exception of Sprr2f are expressed by
E15.5 as previously described in the newly differentiated
dorsal epidermis of the developing mouse embryo (de
Guzman Strong et al., 2010). The genes for which there
were gains of interactions in differentiated keratinocytes had
similar, if not increased, levels of expression at E16.5 relative
to E15.5. These observations further identify a longer range
EDC chromatin topology in differentiated cells (Figure 2a), and
are underestimated given the modest coverage associated with
3C methodology and as not all keratinocytes completely
differentiated. In sum, our results support both shared and
unique chromatin spatial interactions between the 923 epi-
dermal-specific enhancer and EDC gene promoters in prolif-
erating and differentiated primary mouse keratinocytes that
represent the dynamic chromatin architecture of the EDC.
AP-1 transcription factor–binding is required for 923 enhancer
activity and EDC gene expression
To elucidate the molecular mechanism underlying 923
enhancer activity, we performed a bioinformatics search to
identify core transcription factor–binding sequences within
923 that are responsible for driving functional enhancer
activity. Assessment of core enhancer functional activity in
four PhastCons blocks was prioritized and representative of
highly conserved sequences between 28 vertebrate species
and therefore likely to impart function (Siepel et al., 2005;
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Figure 1. 923 Is sensitive to spatiotemporal cues during mouse embryonic epidermal development. (a) Whole-mount lacZ staining of 923-hsp68-lacZ mice
demonstrates 923 activity (b-galactosidase/X-gal blue reactivity) following the spatiotemporal pattern of epidermal barrier formation in the developing embryo by
initial observation of activity at embryonic day (E) 16.5 (dorsal) that migrates ventrally by E17.5. (b) 923 Activity localizes to granular and spinous layers of
embryonic dorsal epidermis with corresponding (c) filaggrin (FLG) and (d) keratin1 (K1) immunofluorescent staining (green). Keratin14 (K14) (red) marks basal
keratinocytes, 20. Dotted lines, basement membrane. Experiments observed inX2 independent mice. (e) 923 Activity (quantitative PCR, lacZ transcript) is noted
at E15.5, E16.5, and E17.5 dorsal epidermis, concomitant with Flg, involucrin (Ivl), and loricrin (Lor) transcription relative to E14.5. Error bars represent mean±SD.
Scale bar¼ 50mm.
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Alexander et al., 2010; Figure 3b). Deletions of blocks 1 and 4
at the 50 and 30 ends of 923 significantly decreased luciferase
activity (Figure 3c), thus demonstrating a functional role for
these blocks for 923 enhancer activity. As deletion of block 1
resulted in the greatest and more significant decrease in
enhancer activity, we prioritized a search for transcription
factor–binding motifs within block 1. We identified an AP-1
transcription factor–binding site (Figure 4a) and hypothesized
that AP-1 is required for 923 enhancer activity. Deletion of the
AP-1-binding site by site-directed mutagenesis led to a
significant decrease in 923 enhancer activity under proliferat-
ing and differentiated conditions (Figure 4b), thus demonstrat-
ing a functional role for AP-1 to mediate 923 enhancer activity
in both physiological states.
To examine a role for AP-1 activity with respect to 923
enhancer activity and EDC gene activation, AP-1 binding was
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Figure 2. The chromatin state of the mouse epidermal differentiation complex (EDC) is dynamic. (a) Semi-quantitative chromosomal conformation capture
(3C-quantitative PCR) assays were performed on primary mouse keratinocytes (proliferating and differentiated). Peaks, frequencies of physical interactions
observed between HindIII restriction fragments containing 923 (green bar) and queried restriction fragments containing/neighboring EDC gene promoters
(black barsþ gray lines) or proximal sequences (gray lines) relative to a cell-ubiquitous Ercc3 control. HindIII fragment (50 of Lce3b) represents a chromatin
interaction that was not enhancer-promoter specific. Peaks, average of at least two biological replicates. Error bars represent the mean±SEM. (b) EDC
gene expression heatmap (fold change) in differentiated versus proliferating keratinocytes based on analysis of three pairwise RNA-seq libraries:
green/yellow¼upregulated, blue¼downregulated, and black¼ no change (Supplementary Table S3 online).
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inhibited by tanshinone IIA (TanIIA) treatment in primary
mouse keratinocytes induced to differentiate (calcium induc-
tion; Ezhkova et al., 2009). Calcium-induced keratinocytes
treated with TanIIA exhibited repressed EDC gene expression
(Figure 5b). Moreover, chromatin immunoprecipitation for
AP-1 (c-Jun) revealed that the repression was associated with
the loss of AP-1 binding to block 1 in 923 in TanIIA-treated,
calcium-induced keratinocytes compared with mock controls
(Figure 4c). Together, the data demonstrate a requirement for
AP-1 in activating EDC gene expression, specifically asso-
ciated with functional AP-1 binding within the 923 enhancer
in vivo.
The c-Jun/AP-1/923 axis regulates the EDC transcriptome by
modulating the chromatin architecture
To identify the mechanism by which AP-1 inhibition represses
EDC gene expression, we returned to 3C assays to examine
the chromatin conformation of the EDC with respect to 923 in
the context of AP-1 pharmacological inhibition. The chroma-
tin conformation was assessed at 48 hours post-TanIIA treat-
ment to best ascertain the direct effects of AP-1 inhibition, as
opposed to secondary effects beyond 48 hours. Although there
were no significant differences in the number of 923-mediated
chromatin interactions in TanIIA-treated versus mock-treated
differentiated keratinocytes (11 vs. 12), only six interactions
were shared (Sprr2a1, Sprr3, Ivl, Lce1d, Lce1e, and 50 of
Lce3b) and were close by (within 325 kb; Figure 5a). More-
over, in TanIIA-treated keratinocytes, there was a loss of 923
interactions with Sprr2b, Sprr2d, Sprr1b, Lce6a, and
2310050C09Rik and a gain of spatial interactions with Sprr1a,
Lce1b, and Lce1c at the relatively extreme 50 and 30 ends of
the EDC reaching as far away as 42 Mb and 866 kb in
S100a13 and Tchh (trichohyalin), respectively. Despite the
gain of chromatin interactions, no appreciable differences in
gene expression for Sprr1a, Lce1b, Lce1c, S100a13, and Tchh
were observed. It appears that AP-1 pharmacological inhibi-
tion resulting in decreased c-Jun/AP-1 binding at 923
(Figure 4c), was not sufficient to completely abrogate all
chromatin spatial interactions within the EDC that could be
maintained by other transcription factors. However, our data
support a role for AP-1 in mediating proper 923-centric EDC
chromatin conformation for EDC gene activation.
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DISCUSSION
Although 3C assays and recent high-throughput genomic
studies have enhanced our understanding of chromatin archi-
tecture and gene regulatory modules (de Wit and de Laat,
2012), the mechanisms governing chromosomal spatial
interactions are poorly understood. Our studies identify a
molecular mechanism describing transcription factor/
enhancer modulation of a cluster of genes, namely AP-1 in
the EDC architecture required for epidermal differentiation.
We translate a ‘‘linear’’ interpretation (de Wit and de Laat,
2012) of the keratinocyte genome from our studies and
ENCODE, and prioritize functional studies on 923 to eluci-
date the three-dimensional structure or chromatin interactions
within the EDC. Our study demonstrates that 923 displays
epidermal-specific enhancer activity that tracks with the
spatial and temporal pattern of epidermal differentiation and
barrier formation during normal mouse development. We
further elucidate an association of 923 with the coordinate
activation of EDC genes during epidermal differentiation
based on 3C assays that identified nearby chromatin spatial
interactions between 923 and several EDC genes located as far
as 2 Mb away. Specifically, we observe a chromatin state of
the EDC in proliferating keratinocytes that are marked by
fewer cis-spatial interactions with 923 and do not express EDC
genes. By contrast, the chromatin state of the EDC remodels in
differentiated keratinocytes that express many EDC genes, as
demonstrated by greater observed 923-mediated interactions
with EDC gene promoters. Although in vivo knockout studies
for 923 are beyond the scope of this study and would address
the functional role of 923 as an intriguing locus control region
for the EDC during mouse development, our data nevertheless
support a functional role for 923 in mediating the chromatin
spatial interactions of the EDC. In support of this model, a
recent study evaluating a ZF-mediated Ldb1/b-globin locus
control region physical tethering to the b-globin promoter in
GATA-1-deficient erythroid cells demonstrated causality of
chromatin spatial interactions to gene transcription (Deng
et al., 2012). The requirement of the AP-1-binding site for
923 enhancer activity in both proliferating and differentiated
states and the repression of EDC expression by pharmaco-
logical inhibition of AP-1 suggest that the AP-1/923 axis is an
important mechanism to coordinate the EDC transcriptome.
A bioinformatic analysis of transcription factor–binding sites in
923 suggests additional putative transcription factor–binding
sites including CRE-binding protein within PhastCons Block 4
that could likely contribute to 923 enhancer function.
It is interesting to note that even in a proliferative state, the
loss of the AP-1-binding site in 923 led to a significant
decrease in enhancer activity, and chromatin interactions
were observed between EDC gene promoters and 923.
A majority of AP-1 members are expressed in basal keratino-
cytes with a more restricted expression of specific AP-1
members in the suprabasal layers (Jochum et al., 2001). AP-
1 is known to translate extracellular signals to a transcriptional
response (Schonthaler et al., 2011). Together, these observ-
ations and our data suggest a role for AP-1 (c-Jun) in
modulating 923 activity in basal keratinocytes by folding
the EDC chromatin, and for which activation of EDC
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transcription in the terminally differentiated keratinocyte is
driven by the specificity of an AP-1 homo/heterodimeric
partner. Although the epidermis with targeted loss of c-Jun
(Zenz et al., 2003) and c-Jun/JunB (Guinea-Viniegra et al.,
2009) exhibited normal skin morphology (which could be
attributed to compensatory mechanisms to correct for skin
barrier defects (Koch et al., 2000; Huebner et al., 2012)), the
epidermal-specific c-Jun/JunB and JunB knockouts exhibited
inflammatory defects owing to IL-6 and tumor necrosis factor-
a expression, respectively. Together, these observations lay the
groundwork for investigations linking the role of chromatin
architecture in skin barrier as well as in inflammation.
A recent study revealed that chromatin architectural pro-
teins may have a greater role than transcription factors in
mediating promoter–enhancer interactions (Phillips-Cremins
et al., 2013). Genome-wide analysis of chromatin interactions
lost during the differentiation of embryonic stem cells to
neural progenitor cells unveiled a strong colocalization of
the architectural proteins Mediator and cohesin to the
embryonic stem cell-specific interactions, a partial colocaliz-
ation of the Oct4/Sox2/Nanog transcription factors with
Mediator and cohesin, and far fewer interactions that were
enriched for only transcription factors. The roles of Mediator
and cohesin in mediating enhancer–promoter interactions
were validated by the abrogation of an interaction between
Olig1 and a putative embryonic stem cell-specific enhancer in
Mediator and cohesin knockdown cells. These data suggest
that a proportion of AP-1-mediated 923 interactions may in
fact be dependent on the presence of chromatin architectural
proteins that are able to maintain these interactions even when
AP-1 activity is inhibited, whereas a smaller proportion of
interactions are mediated solely by AP-1.
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Figure 5. c-Jun/AP-1 activity is required for 923-mediated chromatin state remodeling to activate epidermal differentiation complex (EDC) gene expression.
(a) Pharmacological inhibition of AP-1 binding using tanshinone IIA (TanIIA; 1.0mg ml1) modulates the chromatin interactions between 923
(green bar) and EDC gene promoters (gray bars; n¼ 2) in differentiated keratinocytes and (b) represses EDC gene expression based on heatmap depiction:
yellow¼upregulated, blue¼downregulated in TanIIA-treated cells relative to mock.
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A genomic study has recently elucidated the chromatin
topologies of the human and mouse genome that are marked
by distinguishing structural topological domains (Dixon et al.,
2012). These domains are stable, highly conserved, and often
demarcated by boundaries enriched for CCCTC-binding factor
(CTCF), housekeeping genes, tRNAs, and short interspersed
nuclear element transposons. That the EDC is also syntenic
and linear across a wide range of metatherian genomes (de
Guzman Strong et al., 2010) suggests a model for the EDC
as a single distinct topological domain. Of note, ENCODE-
annotated CCCTC-binding factor elements flank the gene
families within and just outside the EDC, suggesting a role
for CCCTC-binding factor as boundary elements for a putative
EDC topology (Ernst et al., 2011). More high-throughput and
higher-resolution characterization of the EDC chromatin
conformation using 4C or 5C methodology would certainly
address this hypothesis and depict additional chromatin
interactions in an unbiased manner.
The EDC has been implicated in atopic dermatitis and
psoriasis (Giardina et al., 2006; Palmer et al., 2006;
Sandilands et al., 2007; de Cid et al., 2009; Esparza-
Gordillo et al., 2009; Hirota et al., 2012; Paternoster et al.,
2012). Specifically, discovery of FLG mutations initially in
ichthyosis vulgaris (Smith et al., 2006), particularly in atopic
dermatitis (Palmer et al., 2006), and other atopic diseases such
as asthma and allergic rhinitis (Irvine et al., 2011) highlights
the importance of how even one of the EDC components
broadly affects prevalent allergic diseases. Even at the
exclusion of common FLG mutations, genetic association to
the EDC continues to persist in atopic dermatitis, which
suggests additional genetic variants within the EDC (Morar
et al., 2007; Esparza-Gordillo et al., 2009). Our analysis
provides a genomic framework for which we can begin to
interrogate regulatory element variants as causatives in these
diseases. Although discovery of causative variants is
prioritized in genomic regions in linkage disequilibrium with
identified in genome-wide association studies single-nucleo-
tide polymorphisms, our chromatin experiments suggest the
discovery of causative single-nucleotide polymorphisms that
are not present in linkage disequilibrium but are in ‘‘physical
proximity’’ and trans to genome-wide association study–
identified single-nucleotide polymorphisms.
MATERIALS AND METHODS
Mice
h923-hsp68-lacZ reporter FVB/N mice were housed in pathogen-free,
barrier facilities at NIH (Bethesda, MD) and Washington University
School of Medicine (St Louis, MO). All animal procedures were
approved by the NHGRI Animal Care and Use Committee and
Division of Comparative Medicine Animal Studies Committee,
Washington University. All animal work was conducted in accor-
dance with the Guide for the Care and Use of Laboratory Animals of
the National Institutes of Health. Morning observation of a vaginal
plug was designated as embryonic day (E) 0.5.
LacZ staining and immunohistochemistry
Whole-mount embryos and frozen optimum cutting temperature
freezing medium, (Tissue-Tek, Sakura, Torrance, CA) sections were
stained overnight for b-galactosidase activity, as previously described
(de Guzman Strong et al., 2010), and imaged on a Nikon SMZ 1500
Stereomicroscope and a Nikon Eclipse 80i brightfield microscope
(Nikon, Tokyo, Japan), respectively. Primary antibodies used for
immunofluorescence are rabbit K1 (17iKSCN, 1:500), rabbit FLG
(5C-KSCN, 1:500), and chicken K14 (5560, 1:1000; courtesy of J
Segre). Secondary antibodies used were goat anti-rabbit (Alexa Fluor
488, 1:500) and goat anti-chicken (Alexa Fluor 594, 1:1000) IgG
antibodies (Life Technologies, Frederick, MD). Sections were fixed in
4% paraformaldehyde (Electron Microscopy Sciences, Hatfield, PA)
prior to permeabilization with 0.1% Triton X-100 and subsequent
antibody incubation. Sections were counterstained with SlowFade
Gold antifade reagent with DAPI (Life Technologies) prior to
fluorescent imaging on a Zeiss AxioImager Z1 and captured with
AxioCam MRc and Axiovision software (Carl Zeiss, Stockholm,
Sweden).
3C assay
Primary keratinocytes were isolated from newborn mice as previously
described (Lichti et al., 2008) and plated under proliferating or
differentiating (2.0 mM Ca2þ ) conditions in custom keratinocyte
media. 3C assays were performed as previously described (Hage`ge
et al., 2007). Briefly, approximately 10 million cells were harvested at
72 hours post-calcium treatment and cross-linked with 2%
formaldehyde prior to overnight HindIII (New England BioLabs,
Ipswich, MA) digestion. Each 3C library was assessed for efficient
digestion by qPCR, and then further ligated with T4 DNA ligase (New
England BioLabs) overnight, de-cross-linked using Proteinase K (IBI
Scientific, Peosta, IA), and purified by phenol/chloroform (Life
Technologies). Each putative physical interaction between 923 and
an EDC gene promoter (detected by head-to-head (same strand)
primer pair within 50–150 bp of a HindIII cut site and designed in
NCBI37/mm9, Supplementary Table S1 online) was detected by
qPCR (Quantitect SYBR Green, Qiagen, Chatsworth, CA; ViiA7,
Applied Biosystems, Foster City, CA) in triplicate in 3C libraries of
equivalent concentrations. CT values for each measured interaction
were normalized against CT values across an uncut region and a pan-
cell Ercc3 chromatin interaction (Hage`ge et al., 2007). Positive 3C
interactions represent a minimum average of at least one replicate
from two independent 3C libraries as a criteria to best exclude false
positive and random events.
RNA isolation and analysis
RNA-seq. RNA isolation and analysis are described in
Supplementary Methods online. RNA-seq data have been depos-
ited in the NCBI SRA under accession number PRJNA210793.
qRT-PCR. Real-time qPCR on cDNA (generated using Super-
Script II reverse transcriptase (Life Technologies)) using SYBR
Green was performed in triplicate (Fast SYBR Green Master Mix
ABI ViiA7, Foster City, CA) and normalized to b2-microglobulin.
Only CT values with single peaks on melt-curve analyses were
included. Primers are listed in Supplementary Table S2 online.
Luciferase assay
923 deletion constructs were cloned synthetically (IDT) or by PCR
amplification. AP-1 site deletion was generated by site-directed
mutagenesis (QuikChange Site-Directed Mutagenesis Kit, Agilent,
IY Oh et al.
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Palo Alto, CA). All clones were verified by Sanger sequencing. Dual
luciferase assays were performed in duplicate as previously described
(de Guzman Strong et al., 2010).
Transcription factor–binding prediction
Transcription factor–binding sites were predicted by aligning each
PhastCons block sequence (with a relative profile score threshold of
80%) against the JASPAR CORE database of transcription factor–
binding profiles (http://jaspar.genereg.net/; Bryne et al., 2008).
AP-1 binding–inhibition assay
Primary keratinocytes grown under differentiating conditions (2.0 mM
Ca2þ ) were treated with either 1. 0mg ml 1 TanIIA (Biomol, Plymouth
Meeting, PA) or DMSO (mock) during calcium shifting 24 hours after
plating. Cells were harvested at 2 days post-calcium treatment for 3C
assays and RNA isolation for gene expression analysis by real-time
qPCR.
Chromatin immunoprecipitation
Chromatin (approximately 5 106 cells) was sonicated (Bioruptor XL
(Diagenode, Denville, NJ)) prior to immunoprecipitation with rabbit
antibodies: c-Jun (AP-1; Abcam, Cambridge, MA; Cat. # ab31419)
and IgG (Millipore, Billerica, MA; Cat. #12-370) antibodies
bound to Dynabeads Protein A (Life Technologies). Chromatin
immunoprecipitation primers are listed in Supplementary Table S4
online.
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